Insider Transactions in Q1 2025 at Resmed Inc (RSMDF)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Feb 10
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.08%
|
$238,000
$238.98 P/Share
|
Feb 07
2025
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,009
-1.73%
|
$1,890,124
$236.77 P/Share
|
Feb 07
2025
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,009
+1.7%
|
$808,909
$101.64 P/Share
|
Feb 05
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.52%
|
$484,000
$242.11 P/Share
|
Feb 03
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
64
-0.71%
|
$15,488
$242.42 P/Share
|
Jan 08
2025
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.07%
|
$234,000
$234.04 P/Share
|
Jan 02
2025
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.46%
|
$460,000
$230.99 P/Share
|
Jan 02
2025
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
75
-0.82%
|
$17,250
$230.99 P/Share
|